BBLG

Bone Biologics
BBLG

Overview Fund Activity

7 hedge funds and large institutions have $576K invested in Bone Biologics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KC
1
Kepos Capital
New York
$72K
2
VF
2
Virtu Financial
New York
$23K

Top Sellers

1
SM
1
Sabby Management
Florida
$15.5K
2
Walleye Capital
2
Walleye Capital
New York
$419K
3
MWA
3
MFA Wealth Advisors
Pennsylvania
$0
4
UBS Group
4
UBS Group
Switzerland
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Walleye Capital
1
Walleye Capital
New York
$419K 295,000 -511,159 -63%
KC
2
Kepos Capital
New York
$72K 50,000 +50,000 New
WAM
3
Warberg Asset Management
Illinois
$38.3K 27,000 -3,000 -10%
VF
4
Virtu Financial
New York
$23K 15,932 +15,932 New
SM
5
Sabby Management
Florida
$15.5K 10,817 -1,489,183 -99%
TRCT
6
Tower Research Capital (TRC)
New York
$8.64K 6,041 -2,270 -27%
Wells Fargo
7
Wells Fargo
California
$3 2 -50 -96%
MWA
8
MFA Wealth Advisors
Pennsylvania
– – -96,774 Closed
UBS Group
9
UBS Group
Switzerland
– – -43,653 Closed
Millennium Management
10
Millennium Management
New York
– – -17,824 Closed
CFGS
11
Concourse Financial Group Securities
Alabama
– – – –